Tornier N.V. (TRNX) 20.67 $TRNX
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 81.57 (+0.96), GB: 30.93 (+0.63), TRNX: 20.67 (+0.28), BABY: 39.65 (+0.57), CLLS: 25.15 (-1.57), COHR: 93.01 (+2.60), OMCL: 35.90 (+0.79), NVDQ: 8.81 (unch)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 84.99 (+1.17), TRNX: 20.67 (+0.28)
EndoChoice® Announces Bill Enquist and Dave Mowry Join Board of Directors
PR Newswire - Wed Sep 09, 7:00AM CDT
EndoChoice Holdings, Inc. (NYSE: GI) announced today that William (Bill) R. Enquist, former President of Global Endoscopy for Stryker Corporation (NYSE: SYK), and David (Dave) H. Mowry, President and CEO of Tornier N.V. (NASDAQ: TRNX) will join the EndoChoice Board of Directors effective September 9, 2015.
TRNX: 20.67 (+0.28), GI: 5.04 (+0.25), SYK: 122.29 (+1.26)
Integra LifeSciences to buy Salto Talaris, Salto XT and Silastic (Futura) product portfolio
M2 - Fri Sep 04, 6:16AM CDT
Medical device company Integra LifeSciences Holdings (NasdaqGS:IART) reported on Thursday that it has entered into a definitive agreement to acquire the US rights to Tornier NV's (TRNX) Salto Talaris and Salto XT ankle replacement products and Futura silastic toe replacement products for an undisclosed cash payment.
IART: 81.45 (+0.59), IARTV: 65.00 (-37.45), TRNX: 20.67 (+0.28)
Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V.
GlobeNewswire - Thu Sep 03, 4:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris(R) and Salto XT(TM) ankle replacement products and Tornier's Futura(TM) silastic toe replacement products, for an undisclosed cash payment. The agreement also includes an option to purchase, in the future, the rights to the Salto Talaris(R), Salto XT(TM), Salto Mobile(TM), and Futura(TM) silastic toe replacement products outside the United States.
IART: 81.45 (+0.59), IARTV: 65.00 (-37.45), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Tornier reports 2Q loss
Automated Insights - Wed Aug 05, 5:24PM CDT
AMSTERDAM (AP) _ Tornier NV (TRNX) on Wednesday reported a loss of $9.3 million in its second quarter.
TRNX: 20.67 (+0.28)
Tornier Reports Second Quarter 2015 Results
GlobeNewswire - Wed Aug 05, 3:05PM CDT
Upper Extremity Constant Currency Growth of 11.9% Led by the Aequalis Ascend(TM) Flex
TRNX: 20.67 (+0.28)
Wright Medical Q2 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 30, 10:54AM CDT
Wright Medical Group Inc. (WMGI) reported adjusted loss of 53 cents per share in the second-quarter of 2015, wider than the Zacks Consensus Estimate of a loss of 48 cents.
WMGI: 19.80 (+0.70), ABAX: 50.95 (+2.54), LMAT: 13.70 (+0.14), TRNX: 20.67 (+0.28)
Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015
GlobeNewswire - Wed Jul 29, 3:05PM CDT
Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the close of the regular trading market on Wednesday, August 5, 2015. Due to the Company's pending merger with Wright Medical Group, Inc., which, pending FTC clearance, is expected to close in the third quarter, the company will not host an accompanying conference call.
TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Wright Medical-Tornier Merger Wins Shareholders' Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 19, 1:35PM CDT
Wright Medical Group Inc. (WMGI) and Tornier N.V. (TRNX) recently apprised that the shareholders of both the companies have approved all proposals associated with the pending merger.
WMGI: 19.80 (+0.70), INCR: 39.57 (+0.86), AHS: 42.68 (+1.33), TRNX: 20.67 (+0.28)
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger
GlobeNewswire - Thu Jun 18, 3:00PM CDT
Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) today announced that all proposals related to the combination of Wright and Tornier were approved by both Wright's and Tornier's shareholders.
WMGI: 19.80 (+0.70), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015
GlobeNewswire - Thu May 07, 3:00PM CDT
Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) announced today that the companies have scheduled shareholder meetings for Thursday, June 18, 2015, in connection with the pending merger of Wright and Tornier.
WMGI: 19.80 (+0.70), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook
GlobeNewswire - Tue May 05, 3:01PM CDT
-- Upper extremity constant currency growth of 14.0% led by Aequalis Ascend(R) Flex(TM)
TRNX: 20.67 (+0.28)
Leading 200 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies
M2 - Thu Oct 22, 3:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s5zdn4/global_smallmid) has announced the addition of the "Global Small/Mid Cap Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 Small/Mid cap medical devices/technology/supplies companies globally and covers various aspects of these 200 companies including news, financial/non-financial information and stock market analysis. The health care sector is expanding as more individuals obtain health insurance yet the investment opportunities are shrinking in market cap. Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector - large-cap stocks. Stunning growth opportunities are found among mid-cap and small cap companies where one to three key products are driving performance. Their size makes them easier to follow and their above-average growth rates make them attractive acquisition targets in a consolidating industry. The median top line growth rate among large-cap companies is at 4%, while that in mid-cap companies is about 7% and that in all the small caps is more than 10%. When we look at a sample of the best in small-cap companies, we are looking at 40% growth. The primary reason large-cap companies don't have small-cap-type growth is that, over the last 20 years, the larger caps have acquired or developed devices in sectors that have been penetrated at significantly higher rates than newer sectors. Revenue growth and gross margin expansion are key factors to consider when valuing a medical device company and, especially, a small- to mid-cap medical device company. Highlights - Leading 200 Global Small/Mid Cap medical devices/technology/supplies companies covered - Provides detailed research methodology for deriving the leading 200 Small/Mid Cap companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Small/Mid Cap medical devices/technology/supplies companies - International presence of Global Small/Mid Cap medical devices/technology/supplies companies - Key R&D activities by Global Small/Mid Cap medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 2: Stock Market Performance over 12 Months: Leading 25 Global Small/Mid Cap Medical Devices/Technology/Supplies Companies with Most Increases 3: Key News of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies for Year 2014-15 4: Key Alliances of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 5: International Presence of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 6: Research and Development Activities by Global Small/Mid Cap Medical Devices/Technology/Supplies Companies 7: Mergers and Acquisitions of Global Small/Mid Cap Medical Devices/Technology/Supplies Companies Companies Mentioned - Partial List - AS One Corporation - Abcam Plc - Advanced Medical Solutions Group PLC - Agfa-Gevaert NV - Ambu A/S - Analogic Corp - Asia Optical Company Incorporated - Capitol Health Ltd - Cellectis SA - Coherent Incorporated - Conmed Corporation - Ebos Group Limited - Ginko International Co Ltd - Gooch & Housego PLC - Greatbatch, Inc. - Hartalega Holdings Bhd - Hogy Medical Company Limited - I - Sens Inc - Icu Medical, Inc. - Ilex Medical Limited - Jeol Limited - Natus Medical, Incorporation - Nolato AB - Novadaq Technologies Inc - Omnicell, Inc. - Sorin SpA - Sun Hing Vision Group Holdings Limited - Sunny Optical Technology (Group) Company Limited - Tamron Co Ltd - Tecan Group AG - Thai Optical Group Public Company Limited - Tornier NV - Value Added Technology Co., Limited. - Vitrolife AB - Wonik Company Limited For more information visit http://www.researchandmarkets.com/research/s5...l_smallmid
ALOG: 81.57 (+0.96), GB: 30.93 (+0.63), TRNX: 20.67 (+0.28), BABY: 39.65 (+0.57), CLLS: 25.15 (-1.57), COHR: 93.01 (+2.60), OMCL: 35.90 (+0.79), NVDQ: 8.81 (unch)
Global Medical Devices: Quarterly Investments Review Featuring the Most Recent 200 Business Transactions
M2 - Tue Oct 20, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mqnnl4/global_medical) has announced the addition of the "Global Medical Devices: Quarterly Investments Review " report to their offering. The 'Global Medical Devices: Quarterly Investments Review report' presents the most recent 200 business transactions between the global medical devices/technology/supplies companies are identified, segregated and analyzed to highlight the scope of investments in different sub-industry sectors. Medical device companies are expected to realign their business structures and strategies to compete in the changing global environment (such as growth of emerging markets, health care reform and cost containment). Anticipated changes include company restructuring as well as an increased reliance on strategic alliances and outsourcing for marketing, distribution, research and manufacturing activities. In this context, the author which has been providing company and financial information globally since two decades, brings out Global Medical Devices: Quarterly Investments Review report for global medical devices/technology/supplies companies. Report Highlights: - A guidance business tool which helps the investors in the global medical devices/technology/supplies industry to assess the investment opportunities for the coming months - Helps the investors to familiarize with the existing investment trends in the global medical devices/technology/supplies industry - Helps the global medical devices/technology/supplies companies to know the prevailing sub-industry trends in the global medical devices/technology/supplies business transactions - Presents the key investment strategies applied by the global medical devices/technology/supplies companies - Highlights the favored countries for the deals by the global medical devices/technology/supplies companies - Useful information on trade facilitators' activities to accelerate global medical devices/technology/supplies commerce - Summarizes the recent regulatory developments that are likely to affect the trade approaches of the global medical devices/technology/supplies industry - Summarizes new policies of various governments in global medical devices/technology/supplies industry and its impact on investments globally - Provides at one glance the listing of important transactions across the global medical devices/ technology/supplies sector Companies Mentioned - Simavita Ltd (Australia) - Solborn Incorporated (South Korea) - Sorin SpA (Italy) - Strand Life Sciences Private Limited (India) - Stratec Biomedical AG (Germany) - Straumann Holding AG (Switzerland) - Sunshine Holdings PLC (Sri Lanka) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc (United States) - Tornier NV (Netherlands) - Toumaz Limited (United Kingdom) - TSO3 Inc (Canada) - Varian Medical Systems, Inc. (United States) - Vivoline Medical AB (Sweden) - Voxel SA (Poland) - William Demant Holding (Denmark) - Wound Management Technologies, Inc. (United States) - Yamato Scientific Co, Ltd (Japan) - Zecotek Photonics Inc (Canada) - Zhejiang DA Diagnostics Co Ltd (China) For more information visit http://www.researchandmarkets.com/research/mq...al_medical
VAR: 84.99 (+1.17), TRNX: 20.67 (+0.28)
EndoChoice® Announces Bill Enquist and Dave Mowry Join Board of Directors
PR Newswire - Wed Sep 09, 7:00AM CDT
EndoChoice Holdings, Inc. (NYSE: GI) announced today that William (Bill) R. Enquist, former President of Global Endoscopy for Stryker Corporation (NYSE: SYK), and David (Dave) H. Mowry, President and CEO of Tornier N.V. (NASDAQ: TRNX) will join the EndoChoice Board of Directors effective September 9, 2015.
TRNX: 20.67 (+0.28), GI: 5.04 (+0.25), SYK: 122.29 (+1.26)
Integra LifeSciences to buy Salto Talaris, Salto XT and Silastic (Futura) product portfolio
M2 - Fri Sep 04, 6:16AM CDT
Medical device company Integra LifeSciences Holdings (NasdaqGS:IART) reported on Thursday that it has entered into a definitive agreement to acquire the US rights to Tornier NV's (TRNX) Salto Talaris and Salto XT ankle replacement products and Futura silastic toe replacement products for an undisclosed cash payment.
IART: 81.45 (+0.59), IARTV: 65.00 (-37.45), TRNX: 20.67 (+0.28)
Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V.
GlobeNewswire - Thu Sep 03, 4:30AM CDT
Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris(R) and Salto XT(TM) ankle replacement products and Tornier's Futura(TM) silastic toe replacement products, for an undisclosed cash payment. The agreement also includes an option to purchase, in the future, the rights to the Salto Talaris(R), Salto XT(TM), Salto Mobile(TM), and Futura(TM) silastic toe replacement products outside the United States.
IART: 81.45 (+0.59), IARTV: 65.00 (-37.45), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Tornier reports 2Q loss
Automated Insights - Wed Aug 05, 5:24PM CDT
AMSTERDAM (AP) _ Tornier NV (TRNX) on Wednesday reported a loss of $9.3 million in its second quarter.
TRNX: 20.67 (+0.28)
Tornier Reports Second Quarter 2015 Results
GlobeNewswire - Wed Aug 05, 3:05PM CDT
Upper Extremity Constant Currency Growth of 11.9% Led by the Aequalis Ascend(TM) Flex
TRNX: 20.67 (+0.28)
Wright Medical Q2 Loss Wider than Expected, Sales Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 30, 10:54AM CDT
Wright Medical Group Inc. (WMGI) reported adjusted loss of 53 cents per share in the second-quarter of 2015, wider than the Zacks Consensus Estimate of a loss of 48 cents.
WMGI: 19.80 (+0.70), ABAX: 50.95 (+2.54), LMAT: 13.70 (+0.14), TRNX: 20.67 (+0.28)
Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015
GlobeNewswire - Wed Jul 29, 3:05PM CDT
Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the close of the regular trading market on Wednesday, August 5, 2015. Due to the Company's pending merger with Wright Medical Group, Inc., which, pending FTC clearance, is expected to close in the third quarter, the company will not host an accompanying conference call.
TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Wright Medical-Tornier Merger Wins Shareholders' Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 19, 1:35PM CDT
Wright Medical Group Inc. (WMGI) and Tornier N.V. (TRNX) recently apprised that the shareholders of both the companies have approved all proposals associated with the pending merger.
WMGI: 19.80 (+0.70), INCR: 39.57 (+0.86), AHS: 42.68 (+1.33), TRNX: 20.67 (+0.28)
Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger
GlobeNewswire - Thu Jun 18, 3:00PM CDT
Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) today announced that all proposals related to the combination of Wright and Tornier were approved by both Wright's and Tornier's shareholders.
WMGI: 19.80 (+0.70), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Wright and Tornier Shareholder Meetings Scheduled for June 18, 2015
GlobeNewswire - Thu May 07, 3:00PM CDT
Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) announced today that the companies have scheduled shareholder meetings for Thursday, June 18, 2015, in connection with the pending merger of Wright and Tornier.
WMGI: 19.80 (+0.70), TRNX: 20.67 (+0.28), WMGIZ: 1.26 (-0.09)
Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook
GlobeNewswire - Tue May 05, 3:01PM CDT
-- Upper extremity constant currency growth of 14.0% led by Aequalis Ascend(R) Flex(TM)
TRNX: 20.67 (+0.28)
